According to SPER Market Research, the single cell analysis market is estimated to reach USD 10.57 billion by 2030 with a CAGR of 14.6%.
Rising prevalence of cancer across the globe is a key driver for the growth of single cell analysis market.
Single cell analysis instruments study the genomics, metabolomics, proteomics and transcriptomics on single cell level. Studying the single cells instead of whole populations unfolds various mechanisms which might get unnoticed.
According to the WHO, cancer is the second leading cause of death across the globe. Low- and middle-income countries are not prepared to manage the upcoming burden of the disease due to which timely treatments can not be achieved. Single cell analysis assists in correct diagnosis of the disease and monitoring the progression of the disease along with patient’s response to the treatment.
Single cell analysis produces high quality analysis on cellular level assisting in accurate diagnosis and evaluation of treatment efficiency. Single cell analysis also aids in determining DNA content, monitoring tumor proliferation and enumeration of T-cells. However, the cost of single cell analytical tools is very high coupled with high maintenance and indirect costs associated with it.
The consumables market is the largest product segment by share in this market. The large share of this segment is mainly ascribed by high adoption, wide range of applications, isolation of RNA and DNA and frequent purchase. North America dominated the market by regional segmentation owing to presence of leading players of single cell analysis market in this region, technological advancement and increasing funding for research & development
The global single cell analysis market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as 10x Genomics, Agilent Technologies, Inc., Apogee Flow Systems Ltd., Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Corning Incorporated, Cytek Biosciences, Danaher Corporation, Fluidigm Corporation, Fluxion Biosciences, Illumina, Inc., Luminex Corporation, Menarini Silicon Biosystems, Inc., Merck KGAA, NanoCellect Biomedical, On-chip Biotechnologies Co., Ltd., Oxford Nanopore Technologies, Promega Corporation, QIAGEN N.V., Rarecyte Inc, Sartorius AG, Takara Bio, Tecan Group Ltd., Thermo Fisher Scientific, Inc.
SPER Market Research study aims to provide market dynamics, demand and supply with yearly forecast to 2030. This report provides data for growth estimates and forecasts for product segments- Consumables (Beads, Microplates, Reagents, Assay Kits [Immunoassays, Cell-based Assays], Other Consumables), Instruments (Flow Cytometers, NGS Systems, PCR Instruments, Spectrophotometers, Microscopes, Cell Counters, HCS Systems, Microarrays, Other Instruments, Single Cell Analysis, by Cell Type, Human Cells, Animal Cells, Microbial Cells); for technique segment- Flow Cytometry, Next-generation Sequencing, Polymerase Chain Reaction, Microscopy, Mass Spectrometry, Other Techniques; for application segment- Research Applications (Cancer, Immunology, Neurology, Stem Cell, Other Research Applications), Medical Applications (Noninvasive Prenatal Diagnosis, in Vitro Fertilization, Circulating Tumor Cell Detection); for end user segment- Academic & Research Laboratories, Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories, Cell Banks & IVF Centers. This report also provides the data for key regional segments of North America, Europe, Asia-Pacific and Rest of the World.
This study also encompasses various drivers and restraining factors for this market for the forecast period. Various growth opportunities are also discussed in the report.